"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development Overview
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEW
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEW
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEW
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWExplore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSAn in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTS
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
Artificial intelligence is accelerating opportunities. Realizing the benefits for healthcare requires the right expertise. Together, we can solve the problems of today, and drive the breakthroughs of tomorrow.
LEARN MORE
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA enables genomic research via global access to a network of genomic-clinical data, proprietary technologies that enable federated analytics, and therapeutic area & bioinformatics expertise to help you answer your most pressing research questions.
LEARN MOREOur mission is to accelerate innovation for a healthier world. Together, we can solve customer challenges and improve patient lives.
LEARN MORECareers, culture and everything in between. Find out what’s going on right here, right now.
LEARN MORE
"Improving human health requires brave thinkers who are willing to explore new ideas and build on successes. Unleash your potential with us.
SEARCH JOBSLas enfermedades de la piel como la Dermatitis Atópica y la Alopecia Areata pueden tener un impacto negativo considerable en el paciente al afectar su calidad de vida (CdV), lo que supone una carga para los pacientes a nivel físico, psicológico y mental. El conocimiento y el entendimiento de estas enfermedades han aumentado en todo el mundo con la introducción de tratamientos innovadores que pueden abordar algunas de las necesidades históricas no satisfechas en este ámbito. Sin embargo, el debate en torno a estas enfermedades a nivel de política públicas es limitado en América Latina. Esto debido principalmente a la falta de información acerca del impacto de las enfermedades en un contexto local, la percepción de la sociedad de que estas enfermedades son "cosméticas", el tipo de manifestaciones físicas que no se consideran como discapacitantes y la limitad cobertura de tratamientos innovadores.
Para comprender mejor la situación de estas enfermedades en América Latina, se llevaron a cabo discusiones con expertos de diversos grupos de interés (pagadores, pacientes, cuidadores, médicos y defensores de pacientes) en cuatro países (Argentina, Brasil, Colombia y México). Este informe destaca el entendimiento de estas enfermedades en la actualidad, así como los retos y las barreras para lograr un tratamiento óptimo. El informe también propone iniciativas clave, como la creación de campañas públicas, fortalecimiento de la educación médica continua, la implementación de acuerdos basados en valor con Instituciones y la integración de los diversos grupos defensores de pacientes en coaliciones representativas.
Specialized expertise and customized solutions across 14 therapeutic centers of excellence, including oncology, GI/NASH, pediatrics, neurology and rare diseases.
